Vima Therapeutics raised $60M in Series A funding, led by Atlas Venture. The funds will expand operations and R&D efforts.
Amount Raised
$60 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Vima Therapeutics, a Cambridge, MA-based clinical-stage biotechnology company, raised $60M in Series A funding. The round was led by Atlas Venture, with participation from Access Industries and Canaan. The company intends to use the funds to expand operations and its R&D efforts. Vima is advancing a first-in-class oral therapy in clinical trials.
Quick answer
Vima Therapeutics raised $60 Million in a Series A round, dated May 30, 2025. Investors: Atlas Venture, Canaan and Access Industries. Vima Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Vima Therapeutics raise?
- Vima Therapeutics raised $60 Million in a Series A round on May 30, 2025.
- Who invested in Vima Therapeutics?
- Atlas Venture, Canaan and Access Industries are named as investors in this round.
- What does Vima Therapeutics do?
- Vima Therapeutics is a clinical-stage biotechnology company providing treatments for dystonia and related movement disorders.
- Where is Vima Therapeutics based and how big is it?
- Vima Therapeutics is based in Cambridge, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Vima Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Illimis Therapeutics raised $42M (Series B) on July 14, 2025.
- Renasant Bio raised $55M (Seed) on July 10, 2025.
- Nuclidium raised $98M (Series B) on July 10, 2025.
- CoRegen raised $93M (Funding Round) on July 9, 2025.
- BioSapien raised $8M (Pre-Series A) on July 7, 2025.
- FELIQS raised $9M (Series A) on July 1, 2025.
Who to call at Vima Therapeutics, and when
A new round usually means Vima Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vima Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vima Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vima Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vima Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansVima Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.